These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23225895)

  • 21. Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015.
    Ljolje D; Dimbu PR; Kelley J; Goldman I; Nace D; Macaia A; Halsey ES; Ringwald P; Fortes F; Udhayakumar V; Talundzic E; Lucchi NW; Plucinski MM
    Malar J; 2018 Feb; 17(1):84. PubMed ID: 29458380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. pfmdr1 mutations in imported African Plasmodium falciparum isolates.
    Dippmann AK; Bienzle U; Harms G; Mockenhaupt FP
    Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1148-50. PubMed ID: 18513774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria.
    Humphreys GS; Merinopoulos I; Ahmed J; Whitty CJ; Mutabingwa TK; Sutherland CJ; Hallett RL
    Antimicrob Agents Chemother; 2007 Mar; 51(3):991-7. PubMed ID: 17194834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya.
    Achieng AO; Muiruri P; Ingasia LA; Opot BH; Juma DW; Yeda R; Ngalah BS; Ogutu BR; Andagalu B; Akala HM; Kamau E
    Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):92-9. PubMed ID: 26236581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa.
    Sisowath C; Petersen I; Veiga MI; Mårtensson A; Premji Z; Björkman A; Fidock DA; Gil JP
    J Infect Dis; 2009 Mar; 199(5):750-7. PubMed ID: 19210165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced ex vivo susceptibility of Plasmodium falciparum after oral artemether-lumefantrine treatment in Mali.
    Dama S; Niangaly H; Ouattara A; Sagara I; Sissoko S; Traore OB; Bamadio A; Dara N; Djimde M; Alhousseini ML; Goita S; Maiga H; Dara A; Doumbo OK; Djimde AA
    Malar J; 2017 Feb; 16(1):59. PubMed ID: 28148267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expansion of a Specific Plasmodium falciparum PfMDR1 Haplotype in Southeast Asia with Increased Substrate Transport.
    Calçada C; Silva M; Baptista V; Thathy V; Silva-Pedrosa R; Granja D; Ferreira PE; Gil JP; Fidock DA; Veiga MI
    mBio; 2020 Dec; 11(6):. PubMed ID: 33262257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial.
    Ursing J; Kofoed PE; Rodrigues A; Blessborn D; Thoft-Nielsen R; Björkman A; Rombo L
    J Infect Dis; 2011 Jan; 203(1):109-16. PubMed ID: 21148503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baseline in vivo, ex vivo and molecular responses of Plasmodium falciparum to artemether and lumefantrine in three endemic zones for malaria in Colombia.
    Aponte S; Guerra ÁP; Álvarez-Larrotta C; Bernal SD; Restrepo C; González C; Yasnot MF; Knudson-Ospina A
    Trans R Soc Trop Med Hyg; 2017 Feb; 111(2):71-80. PubMed ID: 28460112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria.
    Happi CT; Gbotosho GO; Folarin OA; Sowunmi A; Hudson T; O'Neil M; Milhous W; Wirth DF; Oduola AM
    Antimicrob Agents Chemother; 2009 Mar; 53(3):888-95. PubMed ID: 19075074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MRP2/ABCC2 C1515Y polymorphism modulates exposure to lumefantrine during artemether-lumefantrine antimalarial therapy.
    Vos K; Sciuto CL; Piedade R; Ashton M; Björkman A; Ngasala B; Mårtensson A; Gil JP
    Pharmacogenomics; 2017 Jul; 18(10):981-985. PubMed ID: 28639487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmodium falciparum genetic factors rather than host factors are likely to drive resistance to ACT in Ghana.
    Hodoameda P; Duah-Quashie NO; Hagan CO; Matrevi S; Abuaku B; Koram K; Quashie NB
    Malar J; 2020 Jul; 19(1):255. PubMed ID: 32669113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.
    Tumwebaze P; Tukwasibwe S; Taylor A; Conrad M; Ruhamyankaka E; Asua V; Walakira A; Nankabirwa J; Yeka A; Staedke SG; Greenhouse B; Nsobya SL; Kamya MR; Dorsey G; Rosenthal PJ
    J Infect Dis; 2017 Feb; 215(4):631-635. PubMed ID: 28039354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.
    Somé AF; Séré YY; Dokomajilar C; Zongo I; Rouamba N; Greenhouse B; Ouédraogo JB; Rosenthal PJ
    Antimicrob Agents Chemother; 2010 May; 54(5):1949-54. PubMed ID: 20231394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changing Pattern of Plasmodium falciparum
    van Loon W; Bergmann C; Habarugira F; Tacoli C; Savelsberg D; Oliveira R; Mbarushimana D; Ndoli J; Sendegeya A; Bayingana C; Mockenhaupt FP
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0090121. PubMed ID: 34228534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola.
    Kiaco K; Teixeira J; Machado M; do Rosário V; Lopes D
    Malar J; 2015 Dec; 14():504. PubMed ID: 26670642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased pfmdr1 copy number and sequence polymorphisms in Plasmodium falciparum isolates from Sudanese malaria patients treated with artemether-lumefantrine.
    Gadalla NB; Adam I; Elzaki SE; Bashir S; Mukhtar I; Oguike M; Gadalla A; Mansour F; Warhurst D; El-Sayed BB; Sutherland CJ
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5408-11. PubMed ID: 21896916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection of
    Maiga H; Grivoyannis A; Sagara I; Traore K; Traore OB; Tolo Y; Traore A; Bamadio A; Traore ZI; Sanogo K; Doumbo OK; Plowe CV; Djimde AA
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34205228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India.
    Valecha N; Srivastava P; Mohanty SS; Mittra P; Sharma SK; Tyagi PK; Pradhan K; Dev V; Singh R; Dash AP; Sharma YD
    Malar J; 2009 May; 8():107. PubMed ID: 19454000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parasites bearing a single copy of the multi-drug resistance gene (pfmdr-1) with wild-type SNPs predominate amongst Plasmodium falciparum isolates from Malawi.
    Nkhoma S; Nair S; Mukaka M; Molyneux ME; Ward SA; Anderson TJ
    Acta Trop; 2009 Jul; 111(1):78-81. PubMed ID: 19426667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.